Immunodiagnostics Market Size, Share, Growth Analysis, By Product(Instruments, Reagents & Consumables), By Application(Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End User(Clinical Laboratories, Hospitals, Physician’s Offices, Others), By Region - Industry Forecast 2024-2031

Changes in eating habits and the adoption of sedentary lifestyles are contributing to the rising prevalence of multiple chronic and infectious diseases around the world. Immunodiagnostics provides accurate and early disease detection, which is expected to make them a mainstay in the healthcare industry as emphasis on improving patient outcomes rises globally.  

Growing investments in medical R&D and rising demand for better diagnostics technologies are projected to help promote innovation in immunodiagnostics technologies. Chemiluminescence immunoassays (CLIA), enzyme-linked immunosorbent assays (ELISA), and rapid point-of-care (POC) diagnostics are projected to be some of the most popular and high in demand advanced immunodiagnostics technologies in the future.  

Regulatory requirements for approval of immunodiagnostics products and technologies vary vastly around the world. Moreover, reimbursement for immunodiagnostics also varies from country to country. This makes it difficult for companies as well as patients to have consistent access to advanced immunodiagnostics products and technologies going forward thereby impeding market growth potential.  

Performing immunodiagnostics tests requires trained and skilled professionals for optimal diagnosis and clear results. However, the healthcare industry is faced with a shortage of such skilled professionals, which is expected to slow down the demand for immunodiagnostics in the long run. This issue is especially prominent in rural and remote parts of the world.